Yike Yang

Dr. Yike Yang

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2021 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
YYYike Yang
Yike Yang
PXPing Xu
Ping Xu
FZFangyu Zhu
Fangyu Zhu
JLJiujiang Liao
Jiujiang Liao
YWYue Wu
Yue Wu
PBPhilip Baker
Philip Baker
Aims: Although preeclampsia (PE) has been attributed to excessive oxidative stress (OS) in the placenta, mild antioxidants failed to prevent PE in clinical trials. As mitochondria are a major source of OS, this study assessed the potential of a potent mitochondria-targeting antioxidant MitoQ in the prevention of PE. Results: Placentas from women with PE and from reduced uterine perfusion pressure (RUPP) mice demonstrated significantly higher OS, along with increased mitochondrial damage and compromised glutathione peroxidase (GPx) activities. MitoQ administration during late gestation alleviated RUPP-induced PE; whereas early-pregnancy MitoQ treatment not only exacerbated blood pressure, fetal growth restriction, and proteinuria but also reduced the labyrinth/spongiotrophoblast ratio and blood sinuses in the labyrinth. Invasion (Matrigel transwell) and migration (wound healing assay) of trophoblasts were greatly improved by 1 μM hydrogen peroxide (H2O2), but this improvement was abolished by MitoQ or MitoTempo. Mild OS enhanced the expression of miR-29b-3p, which regulates five genes involved in viability and mobility, in HTR8-S/Vneo cells. Innovation and Conclusions: Although the potent mitochondrial-targeting antioxidant MitoQ protects against hypertension and kidney damage induced by RUPP in mice when administered in late gestation, it exacerbates the PE-like phenotype when given in early gestation by interfering with placenta formation because mild OS is required to stimulate trophoblast proliferation, invasion, and migration. Eliminating trophoblastic OS during early pregnancy may lead to compromised placentation and a risk of diseases of placental origin. Therefore, antioxidant therapy for pregnant women should be carefully considered.

1 July 2026 in Hypertension
Verified
Journal Article
Closed access
YYYike Yang
Yike Yang
HZHaoyu Zuo
Haoyu Zuo
XMXiaojuan Ma
Xiaojuan Ma
WCWei Chen
Wei Chen
MSMengxing Sun
Mengxing Sun
TLTong Liu
Tong Liu
BACKGROUND: Preeclampsia, a life-threatening hypertensive disorder of pregnancy, has been linked to iron dysregulation, though mechanistic insights remain limited. METHODS: We integrated clinical data, a reduced uterine perfusion pressure mouse model, in vitro trophoblast cell experiments, and placental organoids derived from patients with preeclampsia. Iron metabolism was assessed via mass spectrometry, quantitative polymerase chain reaction, Peris’ Prussian blue staining and immunohistochemistry. Ferroptosis markers and iron transporters were analyzed. Interventions included the iron chelator deferoxamine, antioxidant MitoQ, ferroptosis inhibitor Fer-1 (ferrostatin-1), and the apoptosis inhibitor Z-VAD. RESULTS: Patients with preeclampsia exhibited elevated hemoglobin, ferritin, and serum iron levels from the second trimester, alongside placental iron overload. Single-cell/nucleus RNA sequencing revealed dysregulated iron transporters ( TFRC ↑, DMT1 ↑, FPN ↓) in preeclampsia trophoblasts. Iron overload induced ferroptosis and apoptosis in trophoblasts, evidenced by increased lipid peroxidation (4HNE↑, Gpx4↓), ROS, Tunnel staining positive and cell death, while suppressing PlGF and progesterone secretion. Both deferoxamine and MitoQ rescued these effects in vitro (similar to Ferr-1) and in preeclampsia-derived organoids. The reduced uterine perfusion pressure model confirmed the preservation of iron dyshomeostasis and ferroptosis in preeclamptic placentas, while oral administration of MitoQ was found to reduce 4-hydroxynonenal and malondialdehyde expression in placenta. CONCLUSIONS: Our findings reveal that iron overload and subsequent ferroptosis contribute to placental damage in preeclampsia, suggesting that iron metabolism dysregulation is a critical feature of the disease. This highlights the need to reevaluate iron supplementation protocols in high-risk pregnancies and to consider individualized iron management strategies that balance maternal-fetal iron requirements while minimizing oxidative stress.

3 April 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
YYYike Yang
Yike Yang
YSYu Shao
Yu Shao
HCHuan Chen
Huan Chen
XGXiaoyue Guo
Xiaoyue Guo
YLYingzhi Liang
Yingzhi Liang
YZYangyu Zhao
Yangyu Zhao
Objective To identify the characteristics and treatment approaches for patients with severe postpartum haemorrhage (SPPH) in various midwifery institutions in one district in Beijing, especially those without identifiable antenatal PPH high-risk factors, to improve regional SPPH rescue capacity. Design Retrospective cohort study. Setting This study was conducted at 9 tertiary-level hospitals and 10 secondary-level hospitals in Haidian district of Beijing from January 2019 to December 2022. Participants The major inclusion criterion was SPPH with blood loss ≥1500 mL or needing a packed blood product transfusion ≥1000 mL within 24 hours after birth. A total of 324 mothers with SPPH were reported to the Regional Obstetric Quality Control Office from 19 midwifery hospitals. Outcome measures The pregnancy characteristics collected included age at delivery, gestational weeks at delivery, height, parity, delivery mode, antenatal PPH high-risk factors, aetiology of PPH, bleeding amount, PPH complications, transfusion volume and PPH management. SPPH characteristics were compared between two levels of midwifery hospitals and their association with antenatal PPH high-risk factors was determined. Results SPPH was observed in 324 mothers out of 106 697 mothers in the 4 years. There were 74.4% and 23.9% cases of SPPH without detectable antenatal PPH high-risk factors in secondary and tertiary midwifery hospitals, respectively. Primary uterine atony was the leading cause of SPPH in secondary midwifery hospitals, whereas placental-associated disorders were the leading causes in tertiary institutions. Rates of red blood cell transfusion over 10 units, unscheduled returns to the operating room and adverse PPH complications were higher in patients without antenatal PPH high-risk factors. Secondary hospitals had significantly higher rates of trauma compared with tertiary institutions. Conclusion Examining SPPH cases at various institutional levels offers a more comprehensive view of regional SPPH management and enhances targeted training in this area.

22 December 2025 in Placenta
Verified
Journal Article
Open access
YYYike Yang
Yike Yang
HSHuifeng Shi
Huifeng Shi
HZHaoyu Zuo
Haoyu Zuo
YWYan Wang
Yan Wang
YZYangyu Zhao
Yangyu Zhao
Preeclampsia (PE), particularly when associated with small-for-gestational-age (SGA) infants, is a major cause of maternal and neonatal morbidity. While dysregulated iron metabolism is linked to PE, its role in placental dysfunction and fetal growth restriction remains unclear. In a retrospective case-control study nested within a cohort of 47,289 singleton pregnancies, we compared 1576 PE cases (1275 PE alone; 301 PE + SGA) with 25,634 controls. Propensity score matching (PSM, with ratio of 1:5) was applied to balance baseline covariates. Longitudinal hematologic parameters were assessed across gestation. Placental iron deposition was evaluated by Perls' Prussian blue staining, and iron transporter expression (FTH1, TFR, DMT1, FPN) was measured via RT-qPCR in PE + SGA and matched controls. PE + SGA pregnancies were linked to poorer outcomes, including earlier delivery and lower birthweight. Maternal blood tests revealed elevated ferritin, hemoglobin, and RBC counts-most pronounced in PE + SGA. The PE-SGA group showed persistently higher WBC counts and dynamic platelet changes. Trends across groups mirrored those in the PSM cohort. Placental analysis in PE + SGA cases revealed significant iron accumulation in syncytiotrophoblasts, along with increased expression of iron importers (FTH1, TFR, DMT1) and reduced ferroportin (FPN). Preeclampsia is associated with disrupted iron balance, characterized by maternal iron overload and relative fetal iron insufficiency due to placental dysregulation. The findings support the sub - classification of preeclampsia into placental (PE + SGA) and maternal (PE - SGA) subtypes. This cautions against universal iron supplementation and highlights the need for personalized management.

14 November 2025 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
YYYike Yang
Yike Yang
ZYZhiheng Yu
Zhiheng Yu
HSHuifeng Shi
Huifeng Shi
YWYan Wang
Yan Wang
YZYangyu Zhao
Yangyu Zhao
Premature rupture of membranes (PROM) at ≥ 36 weeks elevates intrauterine infection risks, making timely labor induction the preferred intervention. While oxytocin infusion remains the conventional approach, its efficacy proves suboptimal in cases with unfavorable cervical conditions. Oral low-dose misoprostol emerges as a promising solution. The primary objective of this study was to compare the general obstetric delivery information and outcomes following the administration of oxytocin infusion or oral low-dose misoprostol solution for labor induction in PROM at ≥ 36 weeks women with an unfavorable cervical condition. A retrospective cohort study was conducted at a tertiary general hospital in China from March 2020 to November 2024, comparing oxytocin infusion and oral administration of 25 µg misoprostol every 2 h for labor induction in PROM at ≥ 36 weeks women with a Bishop score < 6. A total of 622 mothers were enrolled, with 297 in the oxytocin group and 325 in the misoprostol group. The rates of vaginal delivery and failed induction of labor were comparable between the two groups. Moreover, the duration of first stage of labor time was shorter in the misoprostol group relative to that of the oxytocin group (9.2 ± 4.8 h vs. 10.3 ± 5.0 h, p = 0.03), as well as the duration of administration to vaginal delivery (22.0 ± 10.8 h vs. 24.4 ± 12.1 h, p = 0.03). The rate of vaginal delivery in 24 h was high following induction with oral misoprostol [61.2% (137/224) vs. 51.2% (103/201), p = 0.04]. Notably, the incidence of uterine hyperstimulation, fetal distress, or suspected intrauterine infection was not significantly different between the two groups; however, there was a markedly lower incidence of overall postpartum hemorrhage (PPH) [8.6% (28/325) vs. 17.8% (53/297), p < 0.001] and severe PPH following vaginal delivery [0.4% (1/224) vs. 3.5% (7/201), p = 0.02] observed in the misoprostol group. Logistic regression analysis revealed that misoprostol administration was negatively associated with the occurrence of PPH (aOR: 0.42; 95% CI: 0.23 ~ 0.76, p < 0.01). In this retrospective single-center study, oral low-dose misoprostol yielded similar effects as oxytocin infusion on labor induction in PROM at ≥ 36 weeks pregnancies with unfavorable cervix, with a potentially lower risk of PPH. Nevertheless, these findings need to be further investigated through prospective multicenter studies.

28 September 2026 in The FASEB Journal
Verified
Journal Article
Open access
WJWenxin Jiang
Wenxin Jiang
YYYike Yang
Yike Yang
XYXiao Yuan
Xiao Yuan
WDWei Deng
Wei Deng
MKMark D. Kilby
Mark D. Kilby
YYYi Yang
Yi Yang
Well‐regulated trophoblast proliferation, migration, invasion, and cell turnover are essential for normal placental development in humans and rodents. Given the established role of oxidative stress in placentation and the redox activity of iron, we investigated whether ferroptosis‐associated redox signaling contributes to trophoblast function and placental development. Placental iron profiling revealed significantly elevated total and ferrous iron levels in first‐trimester human villi compared with term placentas, accompanied by the transcript levels of several iron uptake‐ and reduction‐related genes, including TFRC , DMT1 , ZIP8 , STEAP3 , and STEAP4 , which were elevated in first‐trimester villi. Murine placentas also exhibited gestational changes in iron abundance and iron‐homeostasis‐related gene expression. HO‐1 protein abundance was highest during early gestation and declined thereafter, suggesting a potential association between heme degradation and gestational iron homeostasis. In contrast, placental labile iron pool (LIP) levels showed only modest, statistically nonsignificant changes across gestation, suggesting a relatively stable redox‐active iron pool. Immunofluorescence analyses demonstrated spatially distinct expression of ferroptosis‐associated regulators, with ACSL4 enriched in invasive trophoblast populations and GPX4 predominantly localized in surrounding decidual tissues, suggesting regional heterogeneity in ferroptosis‐associated molecular features during placentation. Functional studies in HTR‐8/SVneo trophoblast cells further demonstrated that mild ferroptosis‐associated redox perturbation induced by low‐dose erastin or ferrous iron enhanced trophoblast migration and invasion without overt cytotoxicity. These effects were attenuated by ferrostatin‐1, deferoxamine mesylate (DFOM), or the mitochondria‐targeted antioxidant MitoQ and were blunted following FTH1 and TFRC knockdown, indicating that trophoblast responsiveness depends on iron availability and ferroptosis‐associated redox signaling. Importantly, these pro‐invasive effects were preserved under physiologically relevant hypoxic conditions. Together, our findings support a model in which gestational changes in placental iron homeostasis are associated with ferroptosis‐related molecular features, while experimentally induced iron‐dependent redox signaling modulates trophoblast behavior. Rather than inducing overt ferroptotic cell death, sublethal iron‐dependent redox perturbation may act as a signaling mechanism influencing trophoblast function during placental development.